Han Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Han Li has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Baiquan Xiao
The GBA National Institute for Nanotechnology Innovation, 136 Kaiyuan Avenue, Guangzhou, 510700, P. R. China
1 shared publicationBinghan Yuan
The GBA National Institute for Nanotechnology Innovation, 136 Kaiyuan Avenue, Guangzhou, 510700, P. R. China
1 shared publication- Chuansheng Zheng
Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
1 shared publication Gaojun Teng
1 shared publication- Guo-Jun Zhang
The Breast Center and the Cancer Institute, International Joint Laboratory on Cancer Molecular Imaging of Yunnan, The Key Laboratory of Molecular Imaging in Oncology of Yunnan, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming, China
1 shared publication Haixia Sun
School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, P. R. China
1 shared publication
Latest Publications
- Open Access
- 29 August 2025
- Published by Elsevier in EngMedicine
- Vol. 2 (4)
Thermosensitive nanogel: An embolic agent for durable and conformal embolization in transarterial chemoembolization of hepatocellular carcinoma
- 29 August 2025
- Published by Elsevier in EngMedicine
- Vol. 2 (4)
Open AccessThermosensitive nanogel: An embolic agent for durable and conformal embolization in transarterial chemoembolization of hepatocellular carcinoma
- 16 October 2023
- Published by Royal Society of Chemistry (RSC) in Environmental Science: Nano
- Vol. 10 (12) , 3357-3365
Toxicology and safety research of poly(N-isopropylacrylamide)-based thermosensitive nanogels
Poly(N-isopropylacrylamide) (PNIPAM) is currently the most studied thermosensitive hydrogel. Due to its low critical transition temperature, which is close to human body temperature, it is widely used in the biomedical field. The temperature-sensitive embolic agent based on PNIPAM nanogel utilizes the sol–gel transition characteristics of PNIPAM at different temperatures to solve the contradiction between the fluidity and embolic performance of traditional embolic agents. However, research on the toxicology and safety of PNIPAM-based biomedical materials has not been widely explored. In this study, for the first time, an embolic agent composed of PNIPAM thermosensitive nanogels was taken as the object of research, to explore systematically the potential toxicology risks. We achieved specific detection of PNIPAM nanogels by fluorescent labeling. On this basis, pharmacokinetic, safety, and effectiveness studies were carried out in different animal and in vitro models, and organs in which free nanogels might accumulate when a large number of nanogels enter the blood circulation were analyzed. The results show that PNIPAM-based nanogels have good biocompatibility. This study aims to provide a relevant toxicology research program for PNIPAM-based nanogels and other medical products that may contain nanomaterials, and promote the clinical application of this biomedical material, which has great potential.
- 16 October 2023
- Published by Royal Society of Chemistry (RSC) in Environmental Science: Nano
- Vol. 10 (12) , 3357-3365
Toxicology and safety research of poly(N-isopropylacrylamide)-based thermosensitive nanogels
Poly(N-isopropylacrylamide) (PNIPAM) is currently the most studied thermosensitive hydrogel. Due to its low critical transition temperature, which is close to human body temperature, it is widely used in the biomedical field. The temperature-sensitive embolic agent based on PNIPAM nanogel utilizes the sol–gel transition characteristics of PNIPAM at different temperatures to solve the contradiction between the fluidity and embolic performance of traditional embolic agents. However, research on the toxicology and safety of PNIPAM-based biomedical materials has not been widely explored. In this study, for the first time, an embolic agent composed of PNIPAM thermosensitive nanogels was taken as the object of research, to explore systematically the potential toxicology risks. We achieved specific detection of PNIPAM nanogels by fluorescent labeling. On this basis, pharmacokinetic, safety, and effectiveness studies were carried out in different animal and in vitro models, and organs in which free nanogels might accumulate when a large number of nanogels enter the blood circulation were analyzed. The results show that PNIPAM-based nanogels have good biocompatibility. This study aims to provide a relevant toxicology research program for PNIPAM-based nanogels and other medical products that may contain nanomaterials, and promote the clinical application of this biomedical material, which has great potential.